GlassScriptPhysician profile
Joseph M Fritz
NPI 1619097763
$4,230.04
in general payments reported to CMS, 2019-2025
40 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 80% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,699 · 2020: $295 · 2021: $31.49 · 2022: $105 · 2023: $395 · 2024: $593 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,089 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,089.21 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $579.87 | 2024-2025 | Vowst |
| Paratek Pharmaceuticals, INC. | $517.71 | 2019-2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $453.08 | 2019-2025 | Zerbaxa, Delstrigo, Dificid |
| Novo Nordisk INC | $367.60 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $267.24 | 2019-2024 | |
| Lilly USA, LLC | $227.31 | 2019-2025 | Zepbound, Mounjaro |
| Amgen INC. | $210.76 | 2019-2025 | Otezla, Repatha, Repatha |
| Tetraphase Pharmaceuticals, INC. | $188.76 | 2019 | |
| Astellas Pharma US INC | $180.62 | 2019-2020 | |
| Insmed, INC. | $112.52 | 2021-2025 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $98.88 | 2019 | |
| Abbott Laboratories | $89.26 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Amarin Pharma, INC. | $74.46 | 2019-2020 | |
| Exact Sciences Corporation | $73.83 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $69.68 | 2019-2024 | Arexvy, Shingrix |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Fritz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.